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Microbiologist should use an optimal and cleat presentation for suscept-
ibility results. cumulative reporting. tracing of epidemiological strains and
adequate comments to optimally inform clinicians.
527 - New technologies and advances in the diagnosis .•.
[We5~ Alternatives to microscopic diagnosis of malaria
T. H:inscheid
Hospital Santa Maria, Lisbon. Portugal
Microscopy of Giemsa-stained thick and thin films remains the current
reference method to diagnose malaria. However. it is time-consuming.
requires expertise in microscopy and maintenance of equipment. In devel-
oping nations scarce resources lead to inadequate diagnostic procedures.
while in affluent countries poor familiarity with mabria may cause mis-
diagnosis. Several alternative tests have; been developed recentl~ Micro-
scopy with Ouorescent stains. including centrifugation (QBC ). show
sensitivities and specificities similar to conventional microscopy. although
much quicker to perform. However. they need spcL;al equipment and
training. especially in the differentiation of species. Dipstick anti~en-detec­
tion of parasite Histidine-Rich-Protein II (HRP II) (parasight '-F, ICT
Malaria®) Lactate dehydrogenase (OptiMAL®) or HRPII/AldoWe (ICT
Malaquick Pf/Pv®) are also quick to perform and do not need any
equipment. These tests show sensitivities and specificities comparable to
microscopy. although at lower parasitaemias sensitivities may decrease
significantly, and they detect only P. falciparum (parasightF~. ICT
Malaria®) or P. falciparum and vivax (OptiMAL®. ICT Malaquick Pf/
Pv®). These dipstick-tests may be useful in remote areas without laboratory
access or in laboratories as back-up to microscopy. e.g. for non-experts
during on-ca11s. Polymerase-chain-reaction assays are more sensitive and
specific than microscopy. however. they are oflimited value in the diagnosis
of acute malaria. Automated blood cell analysers (Cell-Dyn 3500®) are a
novel way to diagnose malaria during routine use for Full-Blood-Counts
and may have the potential to detect malaria cases. even in the absence of
clinical suspicion.
IWe522IVisceral leishmaniasis: New diagnostic approaches
L. Gradoni
Parasitology Dept., Istituto Superiore di Sanita, Rome, Italy
The standard technique for the diagnosis of first episodes and relapses of
visceral leishmaniasis (VL) is the bone marroW' aspirate microscopy and
culture, which results in > 95% sensitivity. However. this is an invasive
procedure which requires experienced microscopists and the availability of
freshly prepared culture media. New diagnostic approaches have been
proposed which. however. must be treated differently in the two cohorts
ofVl patients. i.e. HIV-negative and HIV-infected individuals.
VL in HIV-negative individuals - Antileishmanial antibodies are detected
in 99-100% ofthese patients by a number ofimmunological tests which use
Leishmania crude antigens. Recently. test specificity was greatly increased by
the use of recombinant antigens. Serology should represent the first and.
probably. the sole diagnostic approach in immunocompetent individuals.
Furthermore. serial titration of specific antibodies at 2-3 months intervals
has high prognostic utility in the follow-up of drug treated patients.
Vl in HIV-infected individuals - less than 60-70% ofthese patients have
detectable antileishmanial antibodies; however, 70-75% have parasites in
peripheral blood. Sensitive techniques have been developed to detect
microscopically Leishmania on leukocytoconcentrates, or to amplify leish-
manial DNA (PCR) from buffy-coat or blood-spot filter paper samples.
The use of these noninvasive techniques is of great value in the patient's
follow-up.
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IWe524I Advances in the diagnosis of Toxoplasma infection
Babill Stray-Pedersen
Department ofGynecology and Obstetrics, National Hospital, Oslo, Norway
Toxoplasma infections are wide spread and occur all over Europe. The
infection is usually benign, but can induce severe complications ifit occurs in
a developing fetus or ~n immunocompromised patient.
Exposure to infection v~ri", region~lIy. From 30-90% of women are
non-immune and susceptible to infection. 0.5-5 women per 1000 acquire
the infection during pregnancy with ~n over all fetal transmission rate of
30%.
The diagnosis ofT. infection depends either on identification of parasites
in tissue/body Ouids or on detection ofspecific antibodies. In pregnancy the
diagnostic challenge lies in differentiating between primary maternal infec-
tion which may cause fctal infection and past latent infection which is without
importance. In the fetus and neon~te the challenge is to identify infected cases
at an early stage. while in patients with chorioretinitis or AIDS it is
important to decide if Toxoplasma is involved.
An arsenal of diagnostic assays is available for detection of Toxoplasma
specific antibodies. The EIA method is mostly used both for IgG. IgM and
IgA detection. The direct agglutination is suitable for screening, while
recently the IgG avidity test has proven useful in determining the time of
infection.
Thc PCR method has found its place in diagnosis offetal infection where
the presence ofToxoplasma DNA in amniotic Ouid indicatL"S maternal fetal
transmission.
In the HIV patient the antibody titers arc low or undetectable. A definite
diagnosis has to rely upon antigen detection. In ocular toxoplasmosis
dcmonstration of antibody production in aqueous humor may be helpful.
IWe525! Contact phase activation and bacterial virulence
L. Bjorck
Department ofCell arId Molecular Biology, Lund, Sweden
A starting point for our studies was the observation that high-molecular-
mass kininogen (H-kininogen) binds to the surface of several species of
pathogenic bacteria. H-kininogen is a multifunctional plasma protein which
together with the other components of the contact phase system, factor XI
and factor XII of the blood coagulation system and plasma prekallikrein.
participates in molecular events leading to the activation of the intrinsic
pathway ofblood coagulation, and to the release of bradykinin (BK) from
H-kininogen. BK is a nonapeptide and a primary mediator ofinftammation,
which through the induction ofsecondary mediators such as prostaglandins
and nitric oxide. induces pain. increased vascular permeability and v~sodi­
latation. It was demonstrated that interactions between contact phase factors
and bacterial surface proteins result in the release of BK ~t the site of
infection. Furthermore. an extracellular cysteine protein~se produced by
Streptococcus pyogenes induces a rapid breakdown of H-kininogen and
massive BK rele~se. Fin~lIy. ~bsorption of contact phase proteins and
fibrinogen by bacterial surface proteins causes a hypocoagulatory state.
These molecular mechanisms may contribute to the bleeding disorders and
the hypovolemic hypotension seen in patients with severe infections disease.
IWe526! The role of superantigens and bacterial DNA during
Lethal Shock
K. Heeg
Institute ofMedical Microbiology and Hygiem Philipps-University, Marburg,
Germany
Endotoxin (lPS) has been defined to playa major role during pathogenesis
of infection. Gram-positive bacteria do not contain LPS yet induce strong
responses of innate immune cells. At least two products or components of
gram-positive bacteria have been defined with similar effects. Once. super-
antigens like the staphylococcal enterotoxin B (SEB) activate oligoclonally
T-lymphocytes. This activation results in a burst of cytokine secretion that
can induce a lethal cytokine syndrome. Moreover, SEB induced interferon-
"'( (IFN-"'() modulates the status of macrophages and thus enhances their
response to lPS. Second, bacterial DNA derived from gram-positive or
gram-negative bacteria has been shown to be a potent activator of innate
immune cells. DNA mediated activation is DNA sequence dependent and
relies on the abundance of frcc CpG-dinucleotides which are less frequent
and methylated in mammalian DNA (CG-suppression). Recent studies have
shown, that even synthetic oligonucleotides (DON) displaying a certain
DNA motifs activate efficiently innate immune cells like macrophages or
dendritic cells. Bacteri~1 DNA and CpG-OON induce production of large
amounts of pro-inOammatory cytokines which can induce lethal shock.
However. epG-DNA also can be used to modulate ongoing immune
responses. This effect of CpG-DNA can be used to develop new adjuv:mts
which preferenti~lIy induce Thl-immune responses.
